Barclays analyst Matthew Bouley raised the firm’s price target on Core & Main to $65 from $57 and keeps an Overweight rating on the shares following the earnings report. The firm says Core & Main ...
The average one-year price target for Core Scientific (NasdaqGS:CORZ) has been revised to $25.48 / share. This is an increase of 18.52% from the prior estimate of $21.49 dated November 7, 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results